Optimum effectiveness of intestinal α-glucosidase inhibitors: Importance of uniform distribution through a meal
Open Access
- 1 March 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 41 (3), 511-516
- https://doi.org/10.1093/ajcn/41.3.511
Abstract
A major barrier to the widespread clinical use of an α glucosidase inhibitor such as Acarbose, is the unpleasant gastrointestinal symptoms of carbohydrate malabsorption associated with its use. Acarbose is usually administered as a tablet and eaten with the first mouthful of the meal, making its uniform distribution through the meal unlikely. In the present study, Acarbose was crushed to a powder and mixed through a test meal before it was consumed. Six healthy young men consumed test meals containing 75 g carbohydrate either as whole brown rice or as ground brown rice. When Acarbose was uniformly mixed through a ground rice meal prior to digestion it produced dose-dependent reductions in the postprandial glucose, insulin and GIP responses which were evident at doses as low as 12.5 mg. The responses to whole brown rice were intermediate between those to 12.5 and 25 mg Acarbose in ground brown rice. In tablet form Acarbose was only one quarter as effective in flattening the post prandial glucose and insulin responses as it was in powder form. These results highlight the importance of uniform distribution of Acarbose through a carbohydrate meal in order to achieve maximum effectiveness in delaying digestion and absorption and yet not promoting carbohydrate malabsorption.This publication has 21 references indexed in Scilit:
- Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) “Zucker” rats by the α-glucosidase inhibitor acarbose (BAY g 5421)Metabolism, 1982
- Response of Serum Levels of Gastric Inhibitory Polypeptide and Insulin to Sucrose Ingestion During Long-term Application of AcarboseScandinavian Journal of Gastroenterology, 1981
- Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitorMetabolism, 1981
- Exceptionally low blood glucose response to dried beans: comparison with other carbohydrate foods.BMJ, 1980
- COMBINED USE OF GUAR AND ACARBOSE IN REDUCTION OF POSTPRANDIAL GLYCÆMIAThe Lancet, 1979
- The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in manZeitschrift für Die Gesamte Experimentelle Medizin, 1979
- The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in manZeitschrift für Die Gesamte Experimentelle Medizin, 1979
- Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.BMJ, 1979
- SUCROSE MALABSORPTION IN MAN AFTER INGESTION OF α-GLUCOSIDEHYDROLASE INHIBITORThe Lancet, 1978
- BREATH-HYDROGEN TEST FOR SMALL-INTESTINAL BACTERIAL COLONISATIONThe Lancet, 1976